Balakrishnan Brinda 4
4 · Aurinia Pharmaceuticals Inc. · Filed May 23, 2023
Insider Transaction Report
Form 4
Balakrishnan Brinda
Director
Transactions
- Exercise/Conversion
Common Stock
2023-05-18+8,733→ 8,733 total - Award
Common Stock
2023-05-19+9,310→ 18,043 total - Exercise/Conversion
Restricted Stock Units
2023-05-18−8,733→ 0 totalFrom: 2023-05-18→ Common Stock (8,733 underlying) - Award
Stock Option (right to buy)
2023-05-19+15,234→ 15,234 totalExercise: $10.74Exp: 2033-05-19→ Common Stock (15,234 underlying)
Footnotes (3)
- [F1]Each Restricted Stock Unit (RSU) represents a contingent right to receive one share of Issuer Common Stock. The RSUs have no expiration date.
- [F2]Represents grant of the RSUs payable solely in common stock of the Issuer. The shares subject to the RSUs shall vest one year from date of grant.
- [F3]The option vests in twelve equal monthly installments commencing on June 19, 2023.